The rating assignment is based on several factors, including DCH’s recently improved operating performance and leading market share in its service area.
DCH also faces numerous challenges, including high leverage, low liquidity and small size compared to larger competitors in its service area.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that DCH will continue to generate solid operating performance in the coming years.
More articles on healthcare finance:
S&P assigns ‘A+’ rating to Saint Francis Medical Center’s bonds
S&P raises Gillette Children’s Specialty Healthcare’s rating to ‘A’
Acryness chooses Forte Payment Solutions as single gateway provider
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
